Search results for: Diversity of Supply
Filter search results
The Importance of Diversity of Supply in Rare Diseases Markets
23 January 2025
…more targeted and inclusive decision rules to promote supplier diversity and healthcare resilience against the risk of shortages. This consulting report, ‘The Importance of Diversity of Supply in Rare Diseases…
OHE’s submission to a parliamentary inquiry on UK drug shortages
6 October 2025
…of chronic conditions strain the supply chain. For example, increased diagnoses of ADHD have led to higher prescriptions for its treatment– shortages of ADHD medication have persisted since September 2023. 2. Supply-side…
International Women’s Day: Why We #Choosetochallenge
8 March 2021
…and support gender diversity (and other types of diversity for matter). These are smart men too, as they understand that all of us, regardless of gender, will be better off…
OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare
15 June 2020
…the health system (or supply-side CET). The OHE authors’ general framework brings together a bargaining process with elements of the demand and supply side of the pharmaceutical markets. The key result…
Would Waiving COVID-19 Vaccines Patents Save Lives?
18 May 2021
…governments – in delivering six vaccines approved by stringent regulatory authorities within one year of the publication of the genome of the virus, together with the tripling of total global…
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
1 July 2021
…make some of their contracted supply available to the COVAX AMC, although some of this replaces earlier commitments. Practical proposals to increase manufacturing capacity and vaccine supply within a voluntary…
Advancing Rare Disease Care: Challenges and Key Issues
28 February 2025
…of diversity of supply in rare diseases markets. We found that enhancing supplier diversity strengthens healthcare resilience and offers treatment alternatives to patients, thereby improving patient access to innovation and…
The Cost of Drug Shortages
16 September 2024
…been observed across a range of therapeutic areas, particularly in the off-patent generic and biosimilar markets. Optimal policy design and decision-making require an understanding of the root causes of drug…
Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds
3 March 2020
…Group. Novel elements of the model include the incorporation of bargaining and Research & Development (R&D) costs to link pharmaceutical pricing and social surplus (the sum of health gains and…